Cargando…
Integrated Genomic, Transcriptomic and Proteomic Analysis for Identifying Markers of Alzheimer’s Disease
There is an urgent need to identify biomarkers for Alzheimer’s disease (AD), but the identification of reliable blood-based biomarkers has proven to be much more difficult than initially expected. The current availability of high-throughput multi-omics data opens new possibilities in this titanic ta...
Autores principales: | Madrid, Laura, Labrador, Sandra C., González-Pérez, Antonio, Sáez, María E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700271/ https://www.ncbi.nlm.nih.gov/pubmed/34943540 http://dx.doi.org/10.3390/diagnostics11122303 |
Ejemplares similares
-
Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer’s disease
por: Morabito, Samuel, et al.
Publicado: (2020) -
Identifying causal genes for migraine by integrating the proteome and transcriptome
por: Li, Shuang-jie, et al.
Publicado: (2023) -
An integrated transcriptomic and proteomic approach to identify the main Torymus sinensis venom components
por: Scieuzo, Carmen, et al.
Publicado: (2021) -
Identifier mapping performance for integrating transcriptomics and proteomics experimental results
por: Day, Roger S, et al.
Publicado: (2011) -
Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer’s disease
por: Hondius, David C., et al.
Publicado: (2018)